Is AbbVie Stock a Buy?
Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.
Hosted on MSN49m
Williams-Sonoma Stock In Focus As CEO Sells $9.5M In Shares: Retail's Bullish
Shares of Williams-Sonoma ($WSM) were in the spotlight as the company's CEO Laura Alber reportedly sold $9.35 million worth ...